IGI Laboratories, Inc. (NYSE:IG), saw one of its leaders execute a transaction that saw him raise his exposure to the company. Director James C. Gale purchased 5,000 shares of common stock at an average price of $5.9 per share. This transaction began last week and was officially filed today, August 26th. Moreover, a $338.75 million market cap company, IGI Laboratories, Inc. (NYSE:IG) develops, manufactures, fills and packs topical semi-solid and liquid products for cosmetic, cosmeceutical and pharmaceutical customers.
In addition, there are multiple hedge funds involved with the company. Billionaire D.E. Shaw‘s D E Shaw Fund reported a 202% rise in its activity last quarter, and now holds 2.1 million shares worth about $11.1 million; while Renaissance Technologies, the hedge fund run by Billionaire Jim Simons, also saw a rise in its involvement with the company over the last fiscal quarter, by 37%, and now has 252,200 shares worth about $1.3 million.
Disclosure: The author, Daniel Forstein, holds no positions in any stocks mentioned.